pharma news

News

NRG raises £50m to start trials of Parkinson's, ALS drug

NRG Therapeutics' oversubscribed Series B will fund first-in-human trials of a drug targeting mitochondrial dysfunction in neurodegenerative diseases.

News

Servier bets $450m on Fragile X syndrome drug

Servier has pushed its emerging neurology pipeline into the clinical trials stage by licensing a drug for Fragile X syndrome from the UK's Kaerus.

News

Governor Maura Healey speaking at this year's BIO conference in Boston.

Massachusetts bucks HHS, issuing its own COVID guidelines

The Bay State is the first to require insurers to cover the shot for everyone, despite conflicting guidance from RFK's HHS on who should get the jab.

News

Woman at work suffering a symptom of menopause

Poll paints picture of menopause discrimination at work

A survey of women across six countries has found more than a third have experienced some kind of negative impact in the workplace due to menopause.

News

FDA releases previously unseen CRLs in transparency push

The FDA's earlier decision to publish complete response letters was largely a repackaging of existing information, but now it has gone much further.

News

Treeline's $200m Series A extension, and other biofinancings

Recent biotech financings include a $200m round for Treeline, with Enveda, Wugen, CHARM Therapeutics, and MRM Health also in on the action.

NRG raises £50m to start trials of Parkinson's, ALS drug

Servier bets $450m on Fragile X syndrome drug

Massachusetts bucks HHS, issuing its own COVID guidelines

Poll paints picture of menopause discrimination at work

FDA releases previously unseen CRLs in transparency push

Treeline's $200m Series A extension, and other biofinancings

Making direct-to-patient work, with Matt Wadyka

Using AI-driven synthetic personas to take your insights fur...

pharma news

Editor's Picks